Plunkett Research Online: Surface Oncology

SURFACE ONCOLOGY (SURF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF61.....


SURFACE ONCOLOGY

Ticker: SURF
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 714-4096
Fax:
Address: 50 Hampshire Street
Cambridge, MA 02139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Robert RossCEO/Director/President
Jessica FeesCFO/Chief Accounting Officer/Treasurer
See More
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF61.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture